Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7
A proprietary blend of two palmitoyl peptides — Palmitoyl Tripeptide-1 (formerly Pal-GHK) and Palmitoyl Tetrapeptide-7 (formerly Pal-GQPR) — that work synergistically to stimulate collagen, elastin, and hyaluronic acid synthesis in the dermis. One of the most extensively studied and most widely validated topical peptide ingredients in existence, with multiple independent clinical trials demonstrating meaningful wrinkle reduction.
01 — Research Summary
Matrixyl 3000 has an unusually strong clinical evidence base for a cosmetic peptide ingredient — including multiple independent trials (not just manufacturer-sponsored research) and a landmark comparison study that found it outperformed retinol in certain wrinkle reduction measures.
45% reduction in wrinkle volume after 2 months. An independent clinical trial measuring wrinkle volume via profilometry found Matrixyl 3000 at 8% concentration produced 45% reduction in wrinkle volume after 2 months — one of the strongest results recorded for a topical cosmetic ingredient.
Matrixyl outperformed retinol on certain wrinkle measures. A comparative trial found Matrixyl 3000 produced greater wrinkle reduction than equivalent retinol formulations on depth measures, with significantly lower irritation — challenging retinol's position as the gold standard topical anti-aging ingredient.
Significant upregulation of collagen I, III, and HA production. Research confirmed Matrixyl 3000 significantly upregulates synthesis of collagen type I, collagen type III, and hyaluronic acid in fibroblasts — providing the mechanistic foundation for the clinical wrinkle reduction data.
Continued improvement with sustained use — not plateau. A 6-month follow-up study found wrinkle reduction continued to improve throughout the study period rather than plateauing — consistent with a mechanism that builds structural dermis rather than producing a temporary surface effect.
02 — Mechanism of Action
Matrixyl 3000 works upstream of skin structure — stimulating the cells that produce the dermis's structural components rather than providing a temporary surface effect.
Pal-Tripeptide-1 (Pal-GHK) is a palmitoylated fragment of collagen that acts as a matrikine — a fragment that signals to fibroblasts to increase collagen production. The palmitoyl group significantly improves skin penetration by increasing lipophilicity. Fibroblasts interpret it as a signal that collagen has been degraded and needs replacing.
Pal-Tetrapeptide-7 (Pal-GQPR) is an immunomodulating peptide that reduces IL-6 production — one of the pro-inflammatory cytokines that drives chronic low-grade skin inflammation and accelerates skin aging. By reducing this inflammatory signal, it protects existing collagen from degradation.
The two components are complementary: Pal-Tripeptide-1 stimulates new collagen production while Pal-Tetrapeptide-7 protects existing collagen from inflammatory degradation. Together they address both sides of the collagen balance equation — increase production and reduce breakdown.
Beyond collagen, Matrixyl 3000 upregulates elastin synthesis (restoring skin elasticity) and hyaluronic acid production (improving skin hydration and volume). This multi-target ECM restoration explains the broad improvement in skin quality reported in clinical trials.
Matrixyl 3000 is widely available, but product quality varies enormously. Key factors: pH (optimal 5.5–7.0), preservative compatibility, emulsion stability, and whether the peptides are in the water phase (required for efficacy). Products with long ingredient lists placing Matrixyl far down the INCI list likely contain sub-therapeutic concentrations. Look for products where Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 appear in the first half of the ingredient list.
03 — Dosing Protocols
Matrixyl 3000 is topical only. The key variables are concentration and formulation quality — higher listed concentration is only meaningful if the product formulation is optimised.
| Protocol | Dose / Concentration | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard serum | 5–10% | Twice daily | 3–6 months | Apply to face and neck after cleansing. Allow to absorb before heavier products. |
| Eye cream application | 2–5% | Once or twice daily | Ongoing | Periorbital area — lower concentrations appropriate given skin sensitivity. |
| Combined with Argireline | 5% each | Twice daily | 12 weeks+ | Best evidence-backed topical anti-aging combination — neuromodulation plus collagen stimulation. |
| Maintenance | 5% | Once daily | Ongoing | Once wrinkle reduction is achieved, once-daily application maintains results. |
Matrixyl 3000 is exceptionally well tolerated — irritation is rare and it is compatible with nearly all other skincare ingredients including retinol, vitamin C, and AHAs. The main risk is using an underdosed product that provides minimal active ingredient despite marketing claims. Check INCI lists carefully.
04 — Community Experiences
Matrixyl 3000 is a cornerstone ingredient in evidence-based skincare communities. r/SkincareAddiction and r/30PlusSkinCare treat it as a well-established staple rather than an emerging compound — the discussion is about which products formulate it best and how to stack it effectively, rather than whether it works. The comparison with retinol is a frequent discussion point, with many users moving to Matrixyl as a better-tolerated alternative.
These are user-reported experiences from public forums. Not endorsed by Whats That Peptide and should not be interpreted as clinical evidence. Individual results vary. Always consult a healthcare professional.
"It outperformed retinol in the comparison study and almost nobody talks about it. No irritation, no sun sensitivity, can be used morning and night, plays well with everything. The evidence is excellent. Why is this not in everyone's routine?"
"Month 1: subtle. Month 3: noticeable. Month 6: family asking what I'm doing differently. The continued improvement rather than plateau is what distinguishes it from most actives. You have to be patient but it rewards patience..."
"The INCI position tells you almost everything. If Palmitoyl Tripeptide-1 is below the preservatives, the concentration is likely sub-therapeutic. I've wasted money on beautifully packaged products with essentially homeopathic amounts..."
"These two together cover both mechanisms: Matrixyl rebuilds the structure, Argireline prevents the lines from forming in the first place. The clinical synergy data exists. This combination is my core anti-aging protocol..."